These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome. Choi KA, Lee JE, Kim YG, Kim DJ, Kim K, Ko YH, Oh HY, Kim WS, Huh W. Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857 [Abstract] [Full Text] [Related]
3. [Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca]. Madani A, Benhmiddoune L, Zafad S, Harif M, Quessar A, Benchekroun S. Bull Cancer; 2005 Feb; 92(2):193-8. PubMed ID: 15749649 [Abstract] [Full Text] [Related]
4. Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma. Cohen Y, Amir G, Rachmilewitz EA, Polliack A. Haematologica; 2002 Jan; 87(1):ELT04. PubMed ID: 11801488 [No Abstract] [Full Text] [Related]
5. Granulocytic sarcoma of the ovary in a nonleukemic patient. Aguiar RC, Pozzi DH, Chamone DA. Haematologica; 1993 Jan; 78(1):53-5. PubMed ID: 8491421 [Abstract] [Full Text] [Related]
6. [Treatment of Burkitt lymphoma and Burkitt-like lymphoma]. Maruyama D. Rinsho Ketsueki; 2011 Oct; 52(10):1645-54. PubMed ID: 21971242 [No Abstract] [Full Text] [Related]
7. Burkitt's lymphoma in a 45-year-old Nigerian woman. Lawal OO, Ojo OS, Durosinmi MA. Trop Geogr Med; 1990 Jul; 42(3):294-7. PubMed ID: 2293442 [Abstract] [Full Text] [Related]
8. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan. Kojima Y, Hagiwara S, Uehira T, Ajisawa A, Kitanaka A, Tanuma J, Okada S, Nagai H. Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129 [Abstract] [Full Text] [Related]
9. [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives]. Bron D, Vandenheule B, Stryckmans P. Rev Med Brux; 1985 Sep; 6(7):491-5. PubMed ID: 2417298 [No Abstract] [Full Text] [Related]
11. Burkitt's lymphoma-- what is new? Abinya ON. East Afr Med J; 2008 May; 85(5):205-6. PubMed ID: 18814529 [No Abstract] [Full Text] [Related]
12. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis. Hainsworth JD, Wolff SN, Stein RS, Greer JP, Cousar JB, Greco FA. Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406 [Abstract] [Full Text] [Related]
13. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study. Rigacci L, Carrai V, Nassi L, Alterini R, Longo G, Bernardi F, Bosi A. Cancer; 2005 Mar 01; 103(5):970-7. PubMed ID: 15666323 [Abstract] [Full Text] [Related]
14. [Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma]. Suzuki K, Nakazato T, Sanada Y, Mihara A, Tachikawa N, Kurai H, Yoshimura Y, Hayashi H, Yoshida S, Kakimoto T. Rinsho Ketsueki; 2010 Mar 01; 51(3):207-12. PubMed ID: 20379116 [Abstract] [Full Text] [Related]
15. Liposomal cytarabine in cerebrospinal fluid. Boyd K, Jenner M, Treleaven J, Kenny J, Rhoades E. Br J Haematol; 2009 Jun 01; 145(6):679. PubMed ID: 19076172 [No Abstract] [Full Text] [Related]
16. Outcome of B-cell non-Hodgkin lymphoma protocol CCCG-B NHL97: a report from Chinese multi-center cooperative group. Tang JY, Pan C, Chen J, Chen H, Wu Y, Xue H, Zhao H, Gu LJ, Fu RY, Wang YP. Med Pediatr Oncol; 2002 Sep 01; 39(3):212-4. PubMed ID: 12210455 [No Abstract] [Full Text] [Related]
17. Treatment of HIV-associated Burkitt Lymphoma in the presence of severe hepatic dysfunction. Chen R, Abbott BL, Myint H. Clin Adv Hematol Oncol; 2006 Nov 01; 4(11):841-4; discussion 844-7. PubMed ID: 17143254 [No Abstract] [Full Text] [Related]
18. Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial. Ribrag V, Koscielny S, Bosq J, Leguay T, Casasnovas O, Fornecker LM, Recher C, Ghesquieres H, Morschhauser F, Girault S, Le Gouill S, Ojeda-Uribe M, Mariette C, Cornillon J, Cartron G, Verge V, Chassagne-Clément C, Dombret H, Coiffier B, Lamy T, Tilly H, Salles G. Lancet; 2016 Jun 11; 387(10036):2402-11. PubMed ID: 27080498 [Abstract] [Full Text] [Related]
19. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Wang ES, Straus DJ, Teruya-Feldstein J, Qin J, Portlock C, Moskowitz C, Goy A, Hedrick E, Zelenetz AD, Noy A. Cancer; 2003 Sep 15; 98(6):1196-205. PubMed ID: 12973843 [Abstract] [Full Text] [Related]